Oncological Outcomes in Bacillus Calmette-Guérin–naïve High-risk Non–muscle-invasive Bladder Cancer Patients: A Systematic Review on Current Treatment Strategies and Future PerspectivesMattia Longoni, Marco Moschini, José Daniel Subiela et al.|European Urology Oncology|2025Cited by 43
Assessing the Performance of 18F-FDG PET/CT in Bladder Cancer: A Narrative Review of Current EvidenceMara Bacchiani, Andrea Mari, Vincenzo Salamone et al.|Cancers|2023Cited by 23
Impact of the extent of lymph node dissection on survival outcomes in clinically lymph <scp>node‐positive</scp> bladder cancerMarkus von Deimling, Marc A. Furrer, Laura S. Mertens et al.|British Journal of Urology|2023Cited by 19
Implications for diagnosis and treatment strategies in non-muscle invasive bladder cancer with variant histology: a systematic reviewGiuseppe Basile, Roberto Carando, Mario de Angelis et al.|Minerva Urology and Nephrology|2023Cited by 18
Outcomes of <scp>BCG</scp> vs upfront radical cystectomy for high‐risk non‐muscle‐invasive bladder cancerPietro Scilipoti, Marco Moschini, Mattia Longoni et al.|British Journal of Urology|2025Cited by 12